Chicago, USA, 1 December 2025 – In stroke care, every minute counts. Yet hospitals often face barriers to accessing advanced AI tools, from complex integrations to platform fees that limit adoption. Nicolab is changing that. Today, Nicolab announced it will join the Harrison.ai Open Platform as a launch partner, putting its clinically validated StrokeViewer solution into the hands of more healthcare providers faster, and without the traditional markup.
Starting in 2026, StrokeViewer will be available through the platform alongside six other leading AI vendors, in an ecosystem built around one principle: hospitals should have access to the best clinical technology in a simple, easy to use platform. Traditional platforms often take 30–60% revenue share, forcing hospitals to weigh cost against access to best-in-class technology. For stroke, where minutes determine outcomes, that trade-off is unacceptable.
The Harrison.ai Open Platform eliminates that barrier. Its zero-markup model and open architecture give hospitals a single integration point for multiple AI vendors, removing extra costs and simplifying access to high-impact tools.
“Healthcare systems should have access to the best AI for their patients, not just what remains affordable after platform fees,” said Michael Macilquham, CEO of Nicolab. “This approach lets us focus on what matters: clinical performance, evidence generation, and supporting clinicians in the moments that count.”
Proven Technology, Broader Reach
StrokeViewer is already approved across the United States (FDA), Europe (MDR), Australia (TGA), New Zealand (Medsafe), APAC, India, and the Middle East. The platform simply removes commercial friction, helping hospitals adopt tools they already know work.
This partnership aligns with Nicolab’s founding mission, born from the MR CLEAN clinical trial in 2015: to make expert stroke care available anywhere, anytime. StrokeViewer connects clinicians across networks, transforming workflow and enabling faster, more informed treatment decisions.
About Nicolab
Nicolab, established in 2015 following the world-leading MR CLEAN clinical trial, is an Australian-based public unlisted company. Comprised of a team of esteemed researchers, developers, and medical specialists, Nicolab is dedicated to developing innovative healthcare solutions that improve patient care. Operating globally, Nicolab’s flagship product, StrokeViewer, enables clinicians to connect, communicate, and collaborate effectively within their stroke network, revolutionizing stroke workflow and treatment planning. Learn more www.nicolab.com
For further information, please contact:
Nicolab
Susan DiGiaimo
Sales Consultant – USA
sdigiaimo@nicolab.com